Hims & Hers Health (HIMS) Gains from Investment Securities (2020 - 2025)
Hims & Hers Health (HIMS) has disclosed Gains from Investment Securities for 6 consecutive years, with -$94.4 million as the latest value for Q4 2025.
- Quarterly Gains from Investment Securities fell 278.4% to -$94.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $518000.0 through Dec 2025, down 99.01% year-over-year, with the annual reading at $518000.0 for FY2025, 99.01% down from the prior year.
- Gains from Investment Securities hit -$94.4 million in Q4 2025 for Hims & Hers Health, down from $94.9 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $94.9 million in Q3 2025 to a low of -$94.4 million in Q4 2025.
- Historically, Gains from Investment Securities has averaged $3.2 million across 5 years, with a median of $243500.0 in 2022.
- Biggest YoY gain for Gains from Investment Securities was 27962.5% in 2021; the steepest drop was 773.08% in 2021.
- Year by year, Gains from Investment Securities stood at -$5.2 million in 2021, then soared by 175.37% to $3.9 million in 2022, then crashed by 120.15% to -$786000.0 in 2023, then surged by 6834.86% to $52.9 million in 2024, then plummeted by 278.4% to -$94.4 million in 2025.
- Business Quant data shows Gains from Investment Securities for HIMS at -$94.4 million in Q4 2025, $94.9 million in Q3 2025, and $83000.0 in Q2 2025.